~~<i id='4B001506E4'><strike id='4B001506E4'><tt id='4B001506E4'><pre id='4B001506E4'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：entertainment 2025-08-14 16:13:54 Page View：694

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA panel issues narrow recommendation for Covid vaccine booster doses
Next article： In age of alternative facts, a scholarly course on calling out crap

comprehensive

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Maui's cultural, historic landmarks damaged in the devastating wildfires

4:12AsatelliteimageshowsanoverviewofBanyancourtinLahaina,Maui,Aug.9,2023.MaxarTechnologiesviaAFP/Get

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

CDC's new outbreak response network to include Northeastern

MarkSchiefelbein/APNortheasternUniversityhasbeenselectedforaleadingroleinanewnationalnetworkformedto